Polaris Rx Named Exclusive U.S. Distributor of AstraZeneca's FluMist® Home Service for Second Consecutive Year

The World's First At-Home Nasal Spray Flu Vaccine Returns for the 2026–2027 Flu Season

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--Polaris Rx, a leading provider of long-term care, specialty, and infusion pharmacy solutions, has once again been selected as the exclusive U.S. distributor for FluMist^® Home, AstraZeneca's at-home flu vaccine service, available for the 2026-2027 flu season. This marks the second consecutive year Polaris Rx has earned this exclusive distinction.

Through FluMist Home, individuals can order FluMist online to be delivered directly to their home without a doctor's visit or needle required. The program remains the first of its kind to receive FDA approval, and Polaris Rx's continued selection as the exclusive distributor reflects the strength of the operational and clinical foundation built during the program's inaugural year. FluMist Home is now available in all 48 contiguous states for the 2026-2027 flu season.

"Being selected for a second year as the exclusive distributor for FluMist Home is a strong validation of the systems and standards we've built at Polaris Rx," said Doug Massey, Chief Executive Officer of Polaris Rx. "We are proud of this partnership and remain committed to advancing preventive care by making flu protection as convenient as possible."

Andrew Leone, Executive Director of Marketing and Sales, U.S. Infectious Disease, AstraZeneca said, "Our continued partnership with Polaris Rx is a testament to the reliability, innovation, and quality they bring to the FluMist Home program. Their expertise in cold chain logistics and their commitment to preventive care make them the right partner as we continue to bring flu protection directly into the homes of families across the country."

Continuing its collaboration with HUB services partner Asembia and ASPN Pharmacies, which provides the technology platform and backend services, Polaris Rx is dispensing and shipping vaccines from two state-of-the-art pharmacy locations this season. Polaris Rx has continued to invest in its patient management and data collection platform and in advanced cold chain capabilities to meet the product's specialized temperature-control requirements, reinforcing the company's ongoing commitment to operational excellence, innovation, and patient care.

To learn more about FluMist Home and to confirm your eligibility, visit https://www.flumist.com/.

About Polaris Rx

Experience the future of pharmacy care with Polaris Rx. As leaders in specialty, infusion, long-term and post-acute care, corrections, and PACE pharmacy solutions, Polaris Rx is elevating pharmacy standards by combining clinical expertise with advanced technology to improve outcomes, optimize costs, and enhance the patient experience. Founded in 2015, Polaris Rx is independently owned with more than 20 pharmacies nationwide.